JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1970) 46, 237-241    DOI: 10.1677/joe.0.0460237
© 1970 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DANON, A.
Right arrow Articles by SULMAN, F. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by DANON, A.
Right arrow Articles by SULMAN, F. G.

IN-VIVO ASSAY FOR HYPOTHALAMIC PROLACTIN-INHIBITING FACTOR

A. DANON, S. DIKSTEIN and F. G. SULMAN

Treatment of intact adult male rats with 10 mg. perphenazine (Trilafon)/kg. resulted in a decrease in the prolactin content of the pituitary within 1 hr. This decrease was probably due to suppression of the hypothalamic prolactin-inhibiting factor (PIF). Subsequent intracarotid infusion of neutralized acid extracts of rat hypothalamus restored the pituitary prolactin content. This effect was dose-dependent within a range of 1/2-2 hypothalami. Infusion of extracts of cerebral cortex failed to increase pituitary prolactin. The response to the hypothalamic extracts is considered to be specific for PIF and is proposed as an assay method for PIF.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1970 by the Society for Endocrinology.